Citius PharmaceuticalsCTXR
13F holders, Q2 2026 (June 30)42holders +4
12new positions
8sold out
1famous investor
$0.60avg. 13F price*
At the end of Q2 2026, 42 institutions reported holding Citius Pharmaceuticals Inc. (CTXR) in their 13F filings, up 4 from Q1 2026. 12 opened new positions and 8 sold out. The largest holders were Geode Capital Management, LLC ($130K), Vanguard Capital Management LLC ($119K) and Miller Financial Services LLC ($79K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Citius Pharmaceuticals Inc.
- CUSIP
- 17322U306
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $129K |
| Exits | 8 | $64K |
All 13F filers, Q1 2026 → Q2 2026: 522,385 shares bought and 159,745 shares sold, net +362,640 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 42 holders
| Geode Capital Management, LLC | 0.00% | Reduce -12.4% | 215,537 | $130K |
| Vanguard Capital Management LLC | 0.00% | Add +17.7% | 197,364 | $119K |
| Miller Financial Services LLC | 0.06% | Add +828.6% | 130,000 | $79K |
| Citadel Advisors | 0.00% | New | 124,910 | $76K |
| Jane Street Group, LLC | 0.00% | Add +445.4% | 122,837 | $74K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 77,755 | $47K |
| BlackRock, Inc. | 0.00% | Reduce 0.0% | 69,850 | $42K |
| Northern Trust Corp. | 0.00% | Add +42.7% | 62,742 | $38K |
| XTX Topco Ltd | 0.00% | Add +178.0% | 59,199 | $36K |
| Asset Advisory Group, Inc. | 0.02% | No change | 59,011 | $36K |
| BostonPremier Wealth LLC | 0.01% | New | 28,000 | $17K |
| UBS Group AG | 0.00% | Reduce -52.1% | 26,335 | $16K |
| LPL Financial LLC | 0.00% | Add +1.6% | 25,445 | $15K |
| State Street Corp. | 0.00% | No change | 23,271 | $14K |
| Virtu Financial LLC | 0.00% | New | 20,836 | $13K |
| Arkadios Wealth Advisors | 0.00% | No change | 20,000 | $12K |
| Two Sigma Investments, LP | 0.00% | Add +33.2% | 17,494 | $11K |
| Sanctuary Advisors, LLC | 0.00% | New | 11,810 | $7K |
| Susquehanna International Group, LLP | 0.00% | Reduce -68.0% | 11,795 | $7K |
| R Squared Ltd | 0.00% | New | 11,033 | $7K |
| Two Sigma Securities, LLC | 0.00% | New | 10,006 | $6K |
| SBI Securities Co., Ltd. | 0.00% | Add +46.0% | 9,519 | $6K |
| Chelsea Counsel Co. | 0.00% | No change | 4,626 | $3K |
| Quent Capital, LLC | 0.00% | Reduce -0.8% | 4,232 | $3K |
| IFP Advisors, Inc | 0.00% | Reduce -40.9% | 4,183 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -2.2% | 2,724 | $2K |
| Osaic Holdings, Inc. | 0.00% | Reduce -5.8% | 2,575 | $2K |
| Group One Trading LLC | 0.00% | New | 1,551 | $938 |
| Simplex Trading, LLC | 0.00% | New | 1,256 | $759 |
| Barclays PLC | 0.00% | New | 1,096 | $663 |
| Wells Fargo & Company | 0.00% | New | 1,000 | $605 |
| Luminist Capital LLC | 0.00% | New | 435 | $263 |
| Assetmark, Inc. | 0.00% | No change | 372 | $225 |
| Princeton Global Asset Management LLC | 0.00% | No change | 160 | $97 |
| Smallwood Wealth Investment Management, LLC | 0.00% | No change | 120 | $72 |
| JPMorgan Chase & Co. | 0.00% | No change | 120 | $69 |
| BNP Paribas Financial Markets | 0.00% | No change | 107 | $65 |
| Arax Advisory Partners | 0.00% | New | 84 | $51 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 80 | $48 |
| Morgan Stanley | 0.00% | Reduce -96.8% | 44 | $27 |
| Fairscale Capital, LLC | 0.00% | No change | 42 | $25 |
| Bogart Wealth, LLC | 0.00% | No change | 4 | $2 |
"% of holder's portfolio" is CTXR's weight in each manager's 13F, not the share of Citius Pharmaceuticals Inc. the manager owns.